Skip to content

Platelet-Rich Fibrin in Intraoral Soft Tissue Regeneration

Role of Platelet-Rich Fibrin in Intraoral Soft Tissue Regeneration of Head and Neck Surgery Patients: A Prospective Clinical Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04022720
Enrollment
0
Registered
2019-07-17
Start date
2019-09-15
Completion date
2020-08-03
Last updated
2020-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucosal Ulceration

Keywords

platelet rich fibrin (PRF)

Brief summary

Determine if the use of platelet rich fibrin (PRF) improves the rate and quality of healing for intraoral mucosal and epithelial soft tissue defects.

Interventions

Platelet Rich Fibrin application at first post-op visit.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Three categories of patients will be included in this study: 1. Osteoradionecrosis (ORN) or medication related osteonecrosis of the jaw (MRONJ) patients who present to clinic with exposed bone and no clinical sign of infection. 2. Patients having an excisional biopsy in clinic performed under local anesthesia resulting in a defect that cannot be easily repaired without compromising normal anatomy or function. These situations include excisions which would result in primary closure under tension or with distorted anatomy, require a local flap, or require healing by secondary intention. 3. Patients presenting to the post-operative clinic with intraoral surgical wound dehiscence or an intraoral surgical wound healing by secondary intention.

Exclusion criteria

* Patients under 18 years of age. * Patient's unable to participate in blood draw either due to medical compromise, inability to tolerate the procedure, or inability of the physician to successfully draw the blood at the time of appointment.

Design outcomes

Primary

MeasureTime frameDescription
Change in rate of healing in intraoral mucosa and epithelium soft tissues3 months post-operativelyImproved healing times of PRF patients compared to control group.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026